Comparison of risk of osteoporotic fracture in Denosumab vs Alendronate treatment within 3 years of initiation
<strong>Importance</strong> Head-to-head randomized clinical trials showed greater efficacy of denosumab vs alendronate in improving bone mineral density. Although there is an association of changes in bone mineral density with reductions in fracture risk, the magnitude of the associati...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
JAMA Network
2019
|